Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Oktober 2021

Biotek-snakken — Oktober 2021

Planlagt Fastgjort Låst Flyttet Biotek-snakken
168 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #105

    Er med Solsen. Mega spændende...

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #106

      To this end, Abbott rates ZYME an Overweight (i.e. Buy) and gives it a $56 price target, suggesting a huge 133% one-year upside potential.

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #107

        Link Preview Image
        Wells Fargo: These 3 Stocks Are Poised to Surge by at Least 40%

        Inflation worries seem to be at the forefront of investors’ concerns right now. However, Mark Smith, senior vice president and portfolio manager at Wells Fargo Advisors, has a solution to put investors at ease: “One of the best ways to combat inflation is through buying equities.” The reopening is “on strong,” people have more money than they ever had, and the banks have kicked off the latest earnings season in style - all are reasons to be “extremely bullish," according to Smith. With this in m

        favicon

        Yahoo Finance (finance.yahoo.com)

        1 Reply Last reply
        0
        • F Offline
          F Offline
          Fandel
          wrote on sidst redigeret af
          #108

          Cantargia rapporterar behandling av första patienten i kliniska studien CESTAFOUR

          1 Reply Last reply
          0
          • B Offline
            B Offline
            BioShare
            wrote on sidst redigeret af
            #109

            Tak Sukkeralf - men lige lidt hjælper det. Det vender forhåbentlig rundt. God weekend hele vejen rundt 🙂

            1 Reply Last reply
            0
            • R Offline
              R Offline
              Rasbom
              wrote on sidst redigeret af
              #110

              Fandel det hjalp desværre ikke meget på kursen. Det ser ud til en hver nyhed bare benyttes til at øge udsalget….

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #111

                Netop opskriften på at gøre små investorer trætte af aktien. Hold ud 🙂

                1 Reply Last reply
                0
                • F Offline
                  F Offline
                  Fandel
                  wrote on sidst redigeret af
                  #112

                  Godmorgen...

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    DevOp
                    wrote on sidst redigeret af
                    #113

                    ATNF: CEO Jim Woody forventer at kunne offentliggøre resultater for Dupuytrens's i Dec (måske 10. dec? :-)) og spændende nyt samarbejde med Celltrion

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #114

                      Best Stocks To Invest In Right Now? 3
                      Health Care Stocks To Watch https://www.proinvestor.com/investornyt/722665/best-stocks-to-invest-in-right-now-3-health-care-stocks-to-watch

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #115

                        2 Biotech Stocks That Could Go Parabolic This Week https://www.proinvestor.com/investornyt/722667/2-biotech-stocks-that-could-go-parabolic-this-week

                        1 Reply Last reply
                        0
                        • F Offline
                          F Offline
                          Fandel
                          wrote on sidst redigeret af
                          #116

                          Godmorgen...

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Pharmafar
                            wrote on sidst redigeret af
                            #117

                            Link Preview Image
                            Novartis top-line results for CANOPY-1 Phase III study support further evaluation of canakinumab in lung cancer

                            favicon

                            Novartis (www.novartis.com)

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #118

                              er det shorts der sættes i Cantargia skal godt nok love for den er blevet trykket ned den sidste lange tid ?

                              1 Reply Last reply
                              0
                              • R Offline
                                R Offline
                                Rasbom
                                wrote on sidst redigeret af
                                #119

                                Novartis fejler Igen med Canakinomab. Der bliver helt sikkert ikke meget at juble over som Cantargia aktionær i dag.

                                1 Reply Last reply
                                0
                                • R Offline
                                  R Offline
                                  Rasbom
                                  wrote on sidst redigeret af
                                  #120

                                  reuters.com

                                  favicon

                                  (www.reuters.com)

                                  1 Reply Last reply
                                  0
                                  • L Offline
                                    L Offline
                                    LP90
                                    wrote on sidst redigeret af
                                    #121

                                    Rasbom Cantargias can 04 og can 10 kan man vel ikke bare sammenligne med med Novartis eller ?

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #122

                                      IL-1rap er en bredere virkningsmekanisme (hæmmer både Il-1 alfa og IL-1 beta, men stadig ikke godt at Novartis fejler med IL-1 beta

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #123

                                        Problemet bliver nok, at ind til der er kørt store randomiserede studier med IL-1 rap altid vil herske en vis usikkerhed. Can 10 sigter dog mod helt andre indikationer, så værdien af dette asset burde ikke berøres sønderligt

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #124

                                          altså usikkerhed i cancer

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper